(Indol-3-yl) -heterocyclic derivatives as agonists of cannabinoid CB1 receptors

摘要

The invention relates to indole derivative having the general Formula (I) Wherein A, XSUB1/SUB, XSUB2/SUB, XSUB3/SUB, Y, RSUB1/SUB, RSUB2/SUB, RSUB3/SUB and RSUB4/SUB are as defined in the claims, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same and to the use of said indol derivatives in the treatment of pain.